NCT06908304 2026-01-12A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLCMaia BiotechnologyPhase 3 Recruiting300 enrolled
NCT00404924 2016-09-30ZD6474 (ZACTIMAâ„¢) Phase III Study in EGFR FailuresSanofiPhase 3 Completed1,140 enrolled 12 charts
NCT00596830 2014-01-13Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma HistologyPfizerPhase 3 Terminated681 enrolled 11 charts